Owkin
Presence
Executives
View the org chart displaying its 33 main executives
Most searched biographies at Owkin
- Thomas Clozel, Chief Executive Officer and Director
- Bruno Raillard, Director
- Jacky Abitbol, Director
Popular executive movements at Owkin
- Jean-Jacques Bienaimé has joined the company as Chairman of the Board (posted on March 25 2024).
- Eric Durand, Senior Vice President, Data Science, has left the company (posted on March 1 2024).
Create your alert
to follow the executive moves at Owkin.
Biotechnology
Owkin has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Owkin
- Owkin has been named one of Forbes’ AI 50 - Owkin
- Owkin expands collaboration with Sanofi leveraging AI for drug positioning in immunology - Owkin
- Press Kit | Owkin
- Bioptimus: The first-ever universal AI foundation model for biology - Owkin
- TechBio Unicorn Owkin Teams Up with AWS to Advance Generative AI for Precision Medicine - Owkin
- UBC Ocean Kaggle competition – Meet the winners - Owkin
- Owkin enters collaboration agreement with MSD to develop AI-powered diagnostics for cancer - Owkin
- Owkin expands reach of AI diagnostic for colorectal cancer through integration with Sectra - Owkin
- Major study validates Owkin’s best in class AI diagnostic for colorectal cancer biomarker aimed at optimizing patient access to immunotherapy - Owkin
- Precision medicine was at the heart of ESMO 2023 - Owkin
- View more press releases Close
Social media about Owkin
- Owkin on Wikipedia, Google News & Yahoo Finance
- Owkin on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Thomas Clozel 
